Karyopharm announces presentations at the 65th american society of hematology annual meeting and exposition (ash)

Long-term selinexor data in myelofibrosis will be presented as part of oral presentation newton, mass. , nov. 2, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that several abstracts that include selinexor data in myelofibrosis (mf) have been selected for presentation at the 65th american society of hematology (ash) annual meeting and exposition, being held december 9-12, 2023, in san diego, ca.
KPTI Ratings Summary
KPTI Quant Ranking